Sanofi SA (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 223   

Articles published

SNY 51.48 +0.19 (0.37%)
price chart
GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR ...
Home > GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR): Are Big Pharma Stocks In Trouble?
Sanofi SA (ADR) New CEO To Focus On US Market
Sanofi SA's (ADR) (NYSE:SNY) former CEO Mr. Viehbacher was sacked primarily because he had a different work ethic than the company's board.
Sanofi Appoints Olivier Brandicourt CEO -- 2nd Update  Nasdaq
Sanofi SA (SNY) Q4 Earnings Preview
Sanofi SA (ADR) (NYSE:SNY) is scheduled to announce its financial results for the fourth quarter of fiscal year 2014 (4QFY14) on Thursday, February 5 before the market opens.
Amgen, Inc., Sanofi SA (ADR)-Regeneron Pharmaceuticals Inc PCSK9 Inhibitors ...
The research, collected from considerably smaller studies sponsored separately by Amgen, Inc. (NASDAQ:AMGN) and Sanofi SA (ADR) (NYSE:SNY) as well as its partner Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), was presented at the annual ...
Amgen, other drug company shares jump on cholesterol drug findings  MarketWatch
Regeneron/Sanofi's PCSK9 Drug Praluent Data Published - Analyst Blog  Nasdaq
Sanofi SA (ADR) Reports Positive Cardiovascular Safety Results For Diabetes ...
Sanofi SA (ADR) (NYSE:SNY) announced Thursday positive results for its diabetes drug Lyxumia from a Phase III study evaluating the cardiovascular risks of the said drug.
Bristol-Myers Squibb Co, Sanofi SA (ADR), and Novartis AG (ADR) Lead 2015 ...
Bristol-Myers Squibb Co (NYSE:BMY), Sanofi SA (ADR)(NYSE:SNY), and Novartis AG's (ADR)(NYSE:NVS) will be 2015's most valuable new drug launches, says a report published on Monday.
Sanofi SA (ADR) (SNY) Launches Inhaled Insulin Afrezza
Sanofi SA (ADR) (NYSE:SNY) has launched its inhalable insulin Afrezza in the US, the company announced before the US markets opened for trading Tuesday.
Sanofi And MannKind Say Inhaled Insulin Afrezza Now Available In U.S.  Nasdaq
Sanofi SA (ADR) (NYSE:SNY) Gets Approval From Japanese Ministry For ...
Sanofi SA (ADR) (NYSE:SNY)-owned Gnezyme, has finally received approval from the Japanese government for the use of Cerdelga, the oral treatment for Gaucher disease type 1. The country's Ministry of Health, Labor and Welfare has approved the use of ...
Stocks Swing on Declaration: Harris Corporation (NYSE:HRS), Sanofi (NYSE ...  eMarketsDaily
Whistleblower Lawsuit Accuses Sanofi SA (SNY), Ousted CEO Of Kickback ...
Sanofi SA (ADR) (NYSE:SNY) has found itself caught in a whistleblower lawsuit, where a former employee is accusing the company of funneling $34 million in kickbacks and incentive payments to various doctors and pharmacies, influencing them to prescribe ...
Related articles »  
Sanofi SA (SNY) Continues Search For Head; Smith & Nephew (SNN) CEO Out ...
In an employee meeting, Smith & Nephew plc (ADR) (NYSE:SNN) Chief Executive Olivier Bohuon dismissed rumors of his plans to leave the medical-device maker to join Sanofi SA (ADR) (NYSE:SNY), as per reports from Bloomberg. This implies that Sanofi, ...
Related articles »